25 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Fearon, Interventional Cardiologist in Stanford, CA?
Dr. William Fearon, MD is an Interventional Cardiologist, who primarily practices in Stanford, CA. He has been practicing for over 25 years and is board certified. Dr. Fearon graduated from Columbia Univ College of Physicians And Surgeons and completed his residency at Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine. Dr. Fearon is fluent in English, and is currently seeing new patients. Dr. Fearon’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Fearon’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Fearon?
Dr. William Fearon, MD is a highly-rated, board-certified Interventional Cardiologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Fearon empowers patients to confidently navigate their health journey, specializing in Aortic Valve Replacement, Coronary Artery Disease, Percutaneous Coronary Intervention, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Fearon is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Fearon go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine CA | Stanford University School of Medicine CA
Residency: Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine | Stanford University Medical Center
Medical School: Columbia Univ Coll of Physicians And Surgeons, New York Ny | Columbia Univ College of Physicians And Surgeons
Is Dr. Fearon board certified as an Interventional Cardiologist?
Yes, Dr. William Fearon, MD is board certified by the American Board of Internal Medicine , American Board of Internal Medicine since 2001, American Board of Internal Medicine since 2002
What languages does Dr. Fearon speak?
Dr. Fearon and their clinical team can communicate with patients in the following languages:
English
What conditions does an Interventional Cardiologist like Dr. Fearon typically treat?
As an Interventional Cardiologist, Dr. Fearon diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Fearon. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Hardening of the Arteries in the Heart without Chest Pain
- Atherosclerosis
- Coronary Artery Disease
- Silent Coronary Artery Disease
- Asymptomatic Atherosclerosis
ICD-10 Codes:
- I2510: Atherosclerotic heart disease of native coronary artery without angina pectoris
Also known as:
- Aortic Valve Disorder
- Narrowed Aortic Valve
- Heart Valve Disease
- Aortic Valve Disease
- Aortic Valve Problem
- Aortic Valve Stenosis
- Tight Aortic Valve
ICD-10 Codes:
- I359: Nonrheumatic aortic valve disorder, unspecified
- I350: Nonrheumatic aortic (valve) stenosis
Also known as:
- Having a Prosthetic Heart Valve
- Heart Valve Disease
- Artificial heart valve
- Mechanical heart valve
- Bioprosthetic valve
ICD-10 Codes:
- Z952: Presence of prosthetic heart valve
What procedures does an Interventional Cardiologist like Dr. Fearon typically perform?
As an Interventional Cardiologist, Dr. Fearon performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Fearon. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Heart Artery Shockwave Treatment
- Coronary lithotripsy
- Intravascular lithotripsy (IVL)
- Heart artery calcification treatment
- Percutaneous coronary lithotripsy
CPT Codes:
- 0715T: Percutaneous transluminal coronary lithotripsy (List separately in addition to code for primary procedure)
Does Dr. Fearon accept my insurance?
Dr. Fearon accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Fearon accept in Stanford, CA?
Dr. Fearon in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
Alignment Healthcare
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Fearon's office located?
Recognitions
Publications
Prognostic Value of the Index of Microcirculatory Resistance Me
Fractiol Flow Reserve-Guided PCI versus Medical Therapy in Stable Corory Disease
, 2012
Functiol SYNTAX Score for Risk Assessment in Multivessel Corory Artery Disease
, 2011
Economic Evaluation of Fractiol Flow Reserve
, 2010
Fractiol Flow Reserve versus Angiography for Guiding Percutaneous Corory Intervention
, 2009
Predictive value of the index of microcirculatory resistance in patients with ST
, 2008
Ratiole and design of the fractiol flow reserve versus angiography for multivessel evaluation
, 2007
Invasive assessment of the corory microcirculation - Superior reproducibility
, 2006
Microvascular resistance is not influenced by epicardial corory artery stenosis severity
, 2004
Novel index for invasively assessing the corory microcirculation
, 2003
Corory Microvascular Dysfunction After ST-Segment-Elevation Myocardial Infarction
, 2013
Fractiol flow reserve assessment of left main stenosis
, 2013
ST-Elevation Myocardial Infarction Following Heart Transplantation as an Unusual Presentation of
, 2013
Physiologic approach for corory intervention.
, 2013
Variability in quantitative and qualitative alysis of intravascular ultrasound
Calculation of the Index of Microcirculatory Resistance Without Corory Wedge Pressure Me
, 2013
Clinical and Functiol Correlates of Early Microvascular Dysfunction After Heart Transplantation
, 2012
The Impact of Downstream Corory Stenoses on Fractiol Flow Reserve Assessment of Intermediate Left
, 2012
The Impact of Sex Differences on Fractiol Flow Reserve
, 2012
The Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous
, 2012
Most accurate definition of a high femoral artery puncture
, 2012
PROGNOSTIC VALUE OF THE INDEX OF MICROCIRCULATORY RESISTANCE AFTER PRIMARY PERCUTANEOUS CORORY
, 2012
Corory Microcirculatory Resistance Is Independent of Epicardial Stenosis
, 2012
Comparison of the Frequency of Corory Artery Disease in Alcohol-Related Versus Non
, 2011
Is a Myocardial Infarction More Likely to Result From a Mild Corory Lesion or an Ischemia
, 2011
Comparison of Drug-Eluting Versus Bare Metal Stents in Cardiac Allograft Vasculopathy
, 2011
Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy
, 2011
The Index of Microcirculatory Resistance (IMR) in Takotsubo Cardiomyopathy
, 2011
CCR2 Antagonist Inhibits Neointimal Proliferation Post CororyStent Deployment
Long-Term Outcomes After Percutaneous Corory Intervention of Left Main Corory Artery for Treatment
, 2010
3 ',4-Dihydroxyflavonol reduces infarct size in a porcine acute myocardial ischaemia-reperfusion
, 2010
CCR2 antagonist inhibits neointimal proliferation post corory stent deployment
, 2010
Outcomes of Percutaneous Corory Intervention
, 2010
Fractiol Flow Reserve Versus Angiography for Guiding Percutaneous Corory Intervention
, 2010
Balloon aortic valvuloplasty: modern indications and techniques for a niche therapy.
, 2010
Angiographic Versus Functiol Severity of Corory Artery Stenoses
, 2010
Intriguing Pen-Strut Low
, 2010
Quantitative assessment of corory microvascular function in patients with
, 2010
Atomic and Functiol Evaluation of Bifurcation Lesions Undergoing Percutaneous Corory Intervention
, 2010
Use of a Low-Profile, Compliant Balloon for Percutaneous Aortic Valvuloplasty
, 2010
Fractiol Flow Reserve
, 2010
Impact of Drug-Eluting Stent Length on Outcomes Less Is More ... More or Less
, 2010
3 ', 4-Dihydroxyflavonol Reduces Infarct Size in a Porcine Acute Myocardial Infarction-Reperfusion
, 2009
Safety and Efficacy of Drug Eluting Stents for Treatment of Cardiac Allograft Vasculopathy
, 2009
Expanding role of fractiol flow reserve in the cardiac catheterization laboratory.
, 2009
Baseline Fractiol Flow Reserve
, 2009
Microvascular Dysfunction
, 2009
Microvascular Drysfunction
, 2009
Safety and Performance of Targeted Rel Therapy: The Be-RITe! Registry
, 2009
Inflammation and cardiovascular disease - Role of the interleukin-1 receptor antagonist
, 2008
Effect of rapamycin therapy on corory artery physiology early after cardiac transplantation
, 2008
In Vivo Comparison Between Optical Coherence Tomography
, 2008
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: Modulation by sirolimus
, 2008
The pathophysiology and clinical course of the normal corory angi syndrome (cardiac syndrome x)
, 2008
Determints of lumen loss between years 1 and 2 after cardiac transplantation
, 2007
Optical coherence tomography compared to intravascular ultrasound
, 2007
Changes in corory atomy and physiology after heart transplantation
, 2007
Prognostic significance of PVCs and resting heart rate
, 2007
Interplay between systemic inflammation
, 2007
Changes in corory arterial dimensions early after cardiac transplantation
, 2007
Aggressive prophylaxis against cytomegalovirus plays a key role
, 2007
Physiologic assessment of rel artery stenosis - Will history repeat itself? Editorial comment
, 2006
Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy
, 2006
Index of microcirculatory resistance
, 2006
Optical coherence tomography: In-vivo correlation withhistology
, 2006
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease
, 2006
Physiological assessment of corory artery disease in the cardiac catheterization laboratory
, 2006
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical
, 2006
Discordant changes in epicardial and microvascular corory physiology after cardiac transplantation
, 2006
Rapamycin therapy improves corory physiology after cardiac transplantation
, 2006
Index of microcirculatory resistance
, 2006
Prevention of subclinical CMV infection reduces cardiac allograft dise
, 2006
Selective rel arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
, 2006
Inhibition of cardiac allograft vasculopathy by sirolimus and mycofenolate
, 2006
Changes in the atomy and physiology of the corory circulation after cardiac transplantation
, 2005
Invasive assessment of the corory microcirculation
, 2005
Design and ratiole for the targeted intra-rel fenoldopam for avoidance of nephropathy
, 2005
Impact of direct corory stenting on neointimal distribution within sirolimus-eluting stents
, 2005
Risk factors for the development of retroperitoneal hematoma after percutaneous
, 2005
Corory endothelial dysfunction in cardiac transplant recipients is related to elevated levels of
, 2005
Pioglitazone-induced heart failure despite normal left ventricular function
, 2004
Tako-tsubo-like left ventricular dysfunction
, 2004
Systemic inflammation links impaired glucose metabolism to cardiac allograft v
, 2004
Corory endothelial dysfunction in cardiac transplant recipients is related to elevated levels of
, 2004
Epicardial stenosis severity does not affect minimal microcirculatory resistance
, 2004
The current and future role of percutaneous corory intervention in patients with corory artery
, 2004
Minimal microvascular resistance is not influenced by epicardial stenosis severity
, 2004
Cytomegalovirus infectious burden is proportiol to cardiac allograft vasculopathy
, 2004
Women remain at higher risk for retroperitoneal hematoma after percutaneous corory intervention
, 2004
Exaggeration of neointimal hyperplasia following stent deployment in type B bifurcation lesions
, 2004
Evaluation of high-pressure retrograde corory venous delivery of FGF-2 protein
, 2004
Comparison of corory thermodilution and Doppler velocity for assessing corory flow reserve
, 2003
Endothelial nitric oxide synthesis is severely impaired after cardiac transplantation: Role of ADMA
, 2003
Simultaneous assessment of fractiol
, 2003
Cost-effectiveness of measuring fractiol flow reserve to guide corory interventions
, 2003
Adjunctive platelet glycoprotein IIb
, 2003
Is corory thermodilution as accurate as Doppler velocity for measuring corory flow reserve?
, 2003
Physiologic interrogation of transplant arterioparthy: Fil results
, 2003
A novel invasive assessment of the corory microcirculation
, 2003
Evaluating intermediate corory lesions in the cardiac catheterization laboratory.
, 2003
Physiologic interrogation of transplant arteriopathy
, 2002
Myocardial delivery of labeled fibroblast growth factor-2 protein by high pressure
, 2002
Corory pressure measurement after stenting predicts adverse events at follow-up
, 2002
High pressure, retrograde
, 2002
A comparison of treadmill scores to diagnose corory artery disease
, 2002
A comparison of angiographic and physiologic correlates to myocardial perfusion
, 2001
Fractiol flow reserve compared with intravascular ultrasound guidance
, 2001
Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men
, 2001
Clinical utility of the exercise ECG in patients with diabetes and chest pain
, 2001
Images in cardiology. Giant left ventricular pseudoaneurysm.
, 2001
Safety and efficacy of high pressure retrograde cardiac venous injection. Implications for regiol
, 2001
Fractiol flow reserve compared to intravascular ultrasound guidance for optimal stent deployment
, 2001
Is the use of fractiol flow reserve to guide corory interventions cost-effective?
, 2001
Use of fractiol myocardial flow reserve to
What is Dr. Fearon's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Fearon's National Provider Identifier (NPI) number is 1770671455.
What common questions do patients ask about Dr. Fearon?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Fearon
What is Dr. William Fearon's specialty?
Dr. Fearon is a Interventional Cardiologist near Stanford, CA.
What does an Interventional Cardiologist do?
A branch of medicine within cardiology that employs advanced imaging and diagnostic techniques to assess blood flow and pressure in the coronary arteries and heart chambers. This specialty also utilizes technical procedures and medications to address abnormalities that affect cardiovascular function.
Is this Dr. William Fearon affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Fearon is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see an Interventional Cardiologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see an Interventional Cardiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is William Fearon accepting new patients in Stanford, CA?
Yes, Dr. William Fearon is accepting new patients at this time.
Does Dr. William Fearon offer online booking?
Please contact Dr. Fearon's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with William Fearon?
Please contact Dr. Fearon's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. William Fearon have?
Dr. William Fearon is certified by the American Board of Internal Medicine.
Other Interventional Cardiologist Near Stanford, CA
Cardiologist
Accepting patientsInterventional Cardiologist
Accepting patientsCardiologist
Accepting patients